<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="6" ids="22696">Beh</z:chebi>Ã§et's disease (BD) is a <z:e sem="disease" ids="C0559758" disease_type="Disease or Syndrome" abbrv="">multisystem disorder</z:e> characterized by <z:hpo ids='HP_0002633'>vasculitis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Pulmonary vascular problems such as <z:hpo ids='HP_0004937'>pulmonary artery aneurysms</z:hpo> (<z:chebi fb="3" ids="51133">PAA</z:chebi>) are reported to indicate poor prognosis and high mortality </plain></SENT>
<SENT sid="2" pm="."><plain>We describe a 43-year-old man who presented with life threatening bilateral <z:chebi fb="3" ids="51133">PAA</z:chebi> and <z:hpo ids='HP_0001907'>thromboembolic disease</z:hpo> due to BD </plain></SENT>
<SENT sid="3" pm="."><plain>He was treated with <z:chebi fb="0" ids="8382">prednisone</z:chebi> and pulse <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> and was poorly responsive to the conventional immunosuppression </plain></SENT>
<SENT sid="4" pm="."><plain>The introduction of adalimumab therapy stabilized his <z:chebi fb="3" ids="51133">PAA</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>We report that the inhibition of TNF-alpha using the neutralizing monoclonal antibody adalimumab has the potential to induce rapid, complete, and long-lasting remission in a life-threatening manifestation of BD </plain></SENT>
</text></document>